Innate Pharma and Takeda sign licence deal to develop ADCs for coeliac disease
Pharmaceutical Technology
APRIL 3, 2023
In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.
Pharmaceutical Technology
APRIL 3, 2023
In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.
Pharmaceutical Technology
MARCH 10, 2023
They offer security in pharmaceutical manufacturing by fulfilling the security rules such as process control settings and specific requirements for the collection of batch production and control records, based on which the pharma products should be produced.
Pharmaceutical Technology
SEPTEMBER 15, 2022
Current demand for API’s is down to several factors, says Georg Bertram, business development manager for turnkey solutions at expert milling solutions company Frewitt. According to Bertram, current insecurities in the supply chain and milling are both drivers, and a lot of API production is also moving from Asia back into Europe.
Let's personalize your content